Design Therapeutics, Inc.
NASDAQ:DSGN
6.25 (USD) • At close December 27, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | |||||||||||||||||
| Current Assets: | |||||||||||||||||
| Cash & Cash Equivalents
| 30.328 | 45.699 | 29.397 | 21.2 | 27.942 | 27.197 | 28.809 | 26.5 | 42.517 | 119.654 | 287.312 | 298.569 | 357.662 | 370.838 | 400.693 | 2.379 | -0.077 |
| Short Term Investments
| 223.746 | 215.317 | 241.289 | 260.598 | 262.998 | 275.891 | 286.583 | 303.887 | 301.716 | 239.723 | 83.908 | 85.495 | 36.056 | 31.998 | 10.646 | 33.712 | 0.154 |
| Cash and Short Term Investments
| 254.074 | 261.016 | 270.686 | 281.798 | 290.94 | 303.088 | 315.392 | 330.387 | 344.233 | 359.377 | 371.22 | 384.064 | 393.718 | 402.836 | 411.339 | 36.091 | 0.077 |
| Net Receivables
| 0 | 1.398 | 1.676 | 1.432 | 1.208 | 0.994 | 0.974 | 1.115 | 0.746 | 0.691 | 0.1 | 0.11 | 0.047 | 0.076 | 0.027 | 0.01 | 0 |
| Inventory
| 0 | 0 | 0 | 0 | -1.208 | -0.994 | -0.974 | -1.115 | 0 | 1.418 | 2.439 | -0.11 | 0 | 0 | 0 | 0.107 | 0 |
| Other Current Assets
| 3.168 | 2.428 | 1.524 | 1.354 | 5.998 | 4.92 | 6.12 | 3.617 | 3.509 | 1.654 | 2.551 | 1.261 | 1.421 | 1.859 | 0.298 | 0.132 | 0 |
| Total Current Assets
| 257.242 | 264.842 | 273.886 | 284.584 | 294.543 | 306.045 | 318.939 | 335.119 | 348.488 | 361.722 | 373.871 | 385.435 | 395.29 | 404.875 | 411.754 | 36.233 | 0.077 |
| Non-Current Assets: | |||||||||||||||||
| Property, Plant & Equipment, Net
| 3.96 | 4.311 | 4.48 | 4.629 | 4.889 | 5.141 | 5.352 | 5.559 | 5.615 | 5.736 | 4.93 | 5.122 | 5.063 | 0.271 | 0.1 | 0.071 | 0 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 239.723 | 0 | 85.495 | 0 | 0 | 0 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 0.427 | 0.429 | 0.427 | 0.43 | 0.437 | 0.444 | 0.452 | 0.459 | 0.466 | -239.249 | 0 | -85.495 | 0 | 0 | 0 | 0.212 | -0.077 |
| Total Non-Current Assets
| 4.387 | 4.74 | 4.907 | 5.059 | 5.326 | 5.585 | 5.804 | 6.018 | 6.081 | 6.21 | 4.93 | 5.122 | 5.063 | 0.271 | 0.1 | 0.283 | -0.077 |
| Total Assets
| 261.629 | 269.582 | 278.793 | 289.643 | 299.869 | 311.63 | 324.743 | 341.137 | 354.569 | 367.932 | 378.801 | 390.557 | 400.353 | 405.146 | 411.854 | 36.516 | 0 |
| Liabilities & Equity: | |||||||||||||||||
| Current Liabilities: | |||||||||||||||||
| Account Payables
| 1.47 | 1.297 | 1.372 | 1.94 | 2.207 | 1.922 | 2.744 | 3.025 | 2.622 | 2.071 | 1.901 | 1.62 | 2.216 | 1.585 | 2.033 | 1.399 | 0 |
| Short Term Debt
| 0.778 | 0.757 | 0.736 | 0.716 | 0.697 | 0.677 | 0.658 | 0.64 | 0.622 | 0.604 | 0.503 | 0.489 | 0.475 | 0 | 0 | 0 | 0 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 0 | 0 | 0 | 0 | -0.697 | -0.677 | 0 | 0 | 0 | 0 | 0 | -2.109 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities
| 5.184 | 4.34 | 4.986 | 6.966 | 9.486 | 9.534 | 5.645 | 7.111 | 7.168 | 4.713 | 3.076 | 3.174 | 2.814 | 1.82 | 1.673 | 0.931 | 0 |
| Total Current Liabilities
| 7.432 | 6.394 | 7.094 | 9.622 | 12.39 | 12.133 | 9.047 | 10.776 | 10.412 | 7.388 | 5.48 | 5.283 | 5.505 | 3.405 | 3.706 | 2.33 | 0 |
| Non-Current Liabilities: | |||||||||||||||||
| Long Term Debt
| 1.744 | 3.892 | 2.142 | 4.668 | 5.044 | 5.404 | 5.756 | 6.102 | 6.438 | 6.762 | 6.024 | 6.288 | 6.546 | 0 | 0 | 0 | 0 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 0 | -1.946 | 0 | -2.334 | -2.522 | -2.702 | -2.878 | -3.051 | -3.219 | -3.381 | -3.012 | -3.144 | -3.262 | 0.14 | 0.142 | 45.501 | 0 |
| Total Non-Current Liabilities
| 1.744 | 1.946 | 2.142 | 2.334 | 2.522 | 2.702 | 2.878 | 3.051 | 3.219 | 3.381 | 3.012 | 3.144 | 3.284 | 0.14 | 0.142 | 45.501 | 0 |
| Total Liabilities
| 9.176 | 8.34 | 9.236 | 11.956 | 14.912 | 14.835 | 11.925 | 13.827 | 13.631 | 10.769 | 8.492 | 8.427 | 8.789 | 3.545 | 3.848 | 47.831 | 0 |
| Equity: | |||||||||||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 400.353 | 405.146 | 411.854 | 45.356 | 0 |
| Common Stock
| 0.006 | 0.006 | 0.006 | 0.006 | 0.006 | 0.006 | 0.006 | 0.006 | 0.006 | 0.006 | 0.006 | 0.006 | 0.006 | 0.006 | 0.006 | 0.001 | 0 |
| Retained Earnings
| -213.563 | -200.524 | -188.731 | -177.626 | -165.784 | -149.995 | -130.058 | -110.764 | -93.424 | -75.72 | -60.721 | -47.456 | -36.391 | -25.073 | -17.437 | -11.923 | 0 |
| Accumulated Other Comprehensive Income/Loss
| 0.914 | -0.217 | -0.167 | 0.062 | -1.283 | -2 | -1.982 | -3.356 | -3.861 | -2.315 | -1.322 | -0.244 | -0.004 | -0.012 | 0.002 | 0.156 | -3.642 |
| Other Total Stockholders Equity
| 465.096 | 461.977 | 458.449 | 455.245 | 452.018 | 448.784 | 444.852 | 441.424 | 438.217 | 435.192 | 432.346 | 429.824 | 427.953 | 426.68 | 425.435 | -44.905 | 0 |
| Total Shareholders Equity
| 252.453 | 261.242 | 269.557 | 277.687 | 284.957 | 296.795 | 312.818 | 327.31 | 340.938 | 357.163 | 370.309 | 382.13 | 391.564 | 401.601 | 408.006 | -11.315 | -3.642 |
| Total Equity
| 252.453 | 261.242 | 269.557 | 277.687 | 284.957 | 296.795 | 312.818 | 327.31 | 340.938 | 357.163 | 370.309 | 382.13 | 391.564 | 401.601 | 408.006 | -11.315 | -3.642 |
| Total Liabilities & Shareholders Equity
| 261.629 | 269.582 | 278.793 | 289.643 | 299.869 | 311.63 | 324.743 | 341.137 | 354.569 | 367.932 | 378.801 | 390.557 | 400.353 | 405.146 | 411.854 | 36.516 | -3.642 |